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CalpainAcrolein, a highly reactive α,β-unsaturated aldehyde, is a product of endogenous lipid peroxidation. It is a
ubiquitous environmental pollutant that is generated mainly by smoke, overheated cooking oil and vehicle
exhaust. Acrolein damages cellular proteins, which could lead to accumulation of aberrantly-folded proteins in
the endoplasmic reticulum (ER). This study determines the mechanisms involved in acrolein-induced apoptosis
mediated by the ER and possible linkswith the ER stress response in humanA549 lung cells. The exposure of cells
to acrolein (15–50 μM) for shorter times of 15 to 30 min activated several ER stress markers. These included the
ER chaperone protein BiP and the three ER sensors: (i) the survival/rescue molecules protein kinase RNA (PKR)-
like ER kinase (PERK) and eukaryotic initiation factor 2 alpha (eIF2α) were phosphorylated; (ii) cleavage of
activating transcription factor 6 (ATF6) occurred, and (iii) inositol-requiring protein-1 alpha (IRE1α) was
phosphorylated. Acrolein (25–50 μM) caused apoptotic cell death mediated by the ER after 2 h, which was
characterised by the induction of CHOP and activation of ER proteases calpain and caspase-4. Calpain and
caspase-7were the initiating factors for caspase-4 activation in acrolein-induced apoptosis. These results increase
our knowledge about cellular responses to acrolein in lung cells, which have implications for human health.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Acrolein is a highly reactive, electrophilic α,β-unsaturated aldehyde
to which humans are exposed in environmental and industrial settings,
particularly as a component of smoke from house and forest ﬁres, ciga-
rettes, cooking oil, smog and automobile exhaust [1,2]. It is also among
the toxic by-products of lipid peroxidation [3,4]. Acrolein has beenprotein kinase B; AMC, amino
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ights reserved.found in water and several foods, and levels are increased further by
cooking. Aldehydes such as acrolein, formaldehyde and acetaldehyde
have been identiﬁed among the most hazardous toxicants in cigarette
smoke [5]. Given that inhalation is themajor route of exposure, acrolein
has been associated with acute lung injury, chronic obstructive pulmo-
nary disease (COPD), asthma, and lung carcinogenesis [6]. Several
studies suggest that acrolein could be involved in Alzheimer's [7–9],
Parkinson's [10], atherosclerosis and cardiovascular diseases [11–13],
diabetes [14,15] and bladder cancers [16].
The high reactivity of acrolein makes it a dangerous substance for
living cells. Acrolein forms adductswith cellular targets such as proteins
and DNA, and disrupts multiple biochemical pathways [1]. Moreover,
acrolein increased the production of reactive oxygen species (ROS) in
human cell types such as A549 [17], macrophages [18], IMR ﬁbroblasts
[19] and HepG2 [20]. Together, these events can lead to cell death by
apoptosis and/or necrosis [21–24], which is dependent on thiol avail-
ability [25], dose (exposure time, concentration) of acrolein, cell type
and cellular environment [1,2,26,27].
The chronic exposure to lowdoses of toxic compounds often leads to
induction of adaptive survival responses, which allow cells and organ-
isms to survive a toxic insult [28,29]. Adaptive responses usually involve
changes in gene and protein expression. Organisms have developed
elaborate defences against toxic stresses. These include antioxidants,
heat shock proteins (HSP), anti-apoptosis proteins (IAPs), and cell sur-
vival signalling pathways involving phosphatidylinositol 3-kinase
(PI3K)/AKT, Ras/mitogen-activated protein kinases (MAPKs), ER stress
and autophagy [30]. If the level of adverse stimulus is low, cells attempt
828 A. Tanel et al. / Biochimica et Biophysica Acta 1843 (2014) 827–835to survive by activating stress responses that protect crucial biochemical
functions such as the elimination of damaged proteins and repair of
DNA damage. When an adverse stimulus is too severe or prolonged,
the defences become overwhelmed and cells are eliminated by process-
es such as apoptosis and/or necrosis.
The endoplasmic reticulum (ER) is a key organelle where newly
synthesized proteins form their correct tertiary structure by post-
translational modiﬁcation, folding and oligomerization [31]. When the
folding capacity of the ER is exceeded, misfolded proteins accumulate
and cause ER stress. The unfolded protein response (UPR) is an adaptive
mechanism that cells use tomitigate ER stress and to restore homeosta-
sis [31]. Eukaryotic cells possess at least three different mechanisms to
adapt to ER stress and attempt to survive: (1) translational attenuation
to limit further accumulation of misfolded proteins through the protein
kinase-like ER resident kinase (PERK) and eukaryotic initiation factor 2
alpha (eIF2α)-mediated pathway; (2) activation of transcription factor
6 (ATF6) and genes encoding ER-resident chaperones such as glucose-
regulated protein-78 (Grp78)/immunoglobulin binding protein (BiP);
and (3) ER-associated degradation (ERAD), which reduces the stress
by directing misfolded ER proteins into the cytosol for degradation by
the 26S proteasome. The ERAD pathway is mediated by activation of
inositol-requiring enzyme 1 alpha (IRE1α), which is triggered by the
dissociation of BiP from the ER luminal domain of IRE1α. If these com-
pensatory mechanisms fail to facilitate the adaptation of cells to ER
stress, induction of the UPR can lead to apoptosis [32].
Acrolein causes protein damage [1,2,33,34], which could lead to
accumulation of misfolded proteins in the ER and induce ER stress.
The A549 cell line was selected for this study due to its human pulmo-
nary origin because the major route of exposure to acrolein is through
inhalation. This study aims to advance our knowledge about this toxic
compound and investigates whether acrolein can activate the ER stress
response and/or apoptosis mediated by the ER. The improved under-
standing of acrolein-induced cellular responses is important given the
widespread chronic exposure of humans to acrolein and the potential
for adverse effects on human health.
2. Material and methods
2.1. Cell culture
A549 cells (#CCL-185, ATCC) were grown in Dulbecco's modiﬁed
Eagle'smedium (InvitrogenCanada, Burlington, ON, Canada) containing
10% fetal bovine serum (FBS) (Invitrogen Canada), 2 mM L-glutamine,
3.7 g/l sodium bicarbonate and 1 mMsodiumpyruvate in tissue culture
ﬂasks (Sarstedt, St-Laurent, QC, Canada) [17]. Near conﬂuent cells were
harvested using 0.25% (w/v) trypsin–0.02% (w/v) EDTA, centrifuged
(1000 g, 3 min) and resuspended in minimum essential medium
alpha (MEMα) containing 10% FBS at pH 7.4.
2.2. Treatment with acrolein
A549 cells (106/ml) were incubated with acrolein (15–50 μM)
(Sigma-Aldrich, Canada, ON, Canada) for different times from 15 min
to 2 h at 37 °C, relative to untreated controls. Where indicated, cells
were pretreated for 1 h with 50 μM calcium chelator BAPTA-AM
(Sigma-Aldrich), 20 μM calpain inhibitor I (Ac-LLnL-CHO) (Sigma-
Aldrich), 50 μM caspase-7/3 inhibitor I (5-[(S)-(+)-2-(methoxymethyl)
pyrrolidino]sulfonylisatin) (Calbiochem) or 20 μM caspase-4 inhibitor
(LEVD-CHO). Cells were washed by centrifugation (1000 ×g, 3 min) to
remove acrolein/inhibitors.
2.3. Western blotting
Whole cell lysates were prepared using washing buffer A (100 mM
sucrose, 1 mM EGTA, 20 mMMOPS, pH 7.4) and lysis buffer B [buffer
A plus 5% Percoll, 0.01% digitonin and cocktail of protease inhibitors[17,35]. Proteins (40 μg) were quantiﬁed [36], separated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) (10% for PERK, p-
PERK, IRE1α, p-IRE1α, BiP, calpastatin; 15% for eIF2α, p-eIF2α, ATF6,
CHOP; 8% for PARP) [37], and transferred to a polyvinylidene diﬂuoride
membrane using a MilliBlot Graphite Electroblotter I apparatus
(Millipore, Bedford, MA, USA) [19]. The blots were probedwith primary
antibodies to ER proteins and GAPDH (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and thenwith horseradish peroxidase (HRP)-conjugated
anti-mouse, anti-rabbit, or anti-goat IgG (Biosource, Camarillo, CA,
USA). Protein levels were analysed using a scanning laser densitometer
(Molecular Dynamics, Sunnyvale, CA, USA) relative to GAPDH [17].
2.4. Caspase and calpain enzymatic activities
Protease activitieswere detected byﬂuorescence spectroscopyusing
a QuadrupleMonochromatorMicroplate Reader (Inﬁnite M1000, Tecan
US, NC, USA) [23]. The following substrates were used: Ac-DEVD-AMC
for caspase-3, Ac-LEVD-AFC for caspase-4, MCA-Val-Asp-Gln-Val-Gly-
Trp-Lys-(DNP)-NH2 for caspase-7 and Suc-LY-AMC for calpain
(Calbiochem, La Jolla, CA, USA). Enzymatic activities are represented
as relative cumulative ﬂuorescence during the 30 min kinetic reaction
and compared to untreated controls. The activation of calpain,
caspases-3, -4 and -7 was conﬁrmed by detection of their cleavage frag-
ments by Western blotting (data not shown).
2.5. Annexin V-FITC staining
Cells (10 000) were labelled with Annexin V-FITC (FL-1) (BD Bio-
sciences Canada, Mississauga, ON, Canada) and propidium iodide
(PI) (FL-3) (Sigma Chemical Co.) and then analysed by ﬂow cytome-
try using a FACScan equipped with an argon laser (488 nm) (Becton
Dickinson, Oxford, UK) [17]. The results are represented as the frac-
tion of total apoptotic cells (early and late stage apoptosis: Annexin
V+/PI±) and necrotic (Annexin V−/PI+) cells.
2.6. Hoechst 33258 staining
Nuclear chromatin condensationwas analysed using Hoechst 33258
(Sigma) by ﬂuorescencemicroscopy (Carl Zeiss Canada Ltd., St. Laurent,
QC) [23]. Necrotic cells were labelled with PI. Photographs were taken
by digital camera (camera 3CCD, Sony DXC-950P, Empix Imaging Inc.,
Mississauga, ON) and images analysed using Northern Eclipse software.
The fractions of apoptotic (blue fragmented chromatin) and necrotic
(red ﬂuorescence) cells were determined relative to total cell number.
A minimum of 300 cells was counted per sample.
2.7. Statistics
Data represent means ± SEM from at least 3 independent experi-
ments performed in duplicate. Comparisons among multiple groups
were made by one-way ANOVA, which measures the linear contrast of
means. The Bonferroni–Holmes adjustment was used to control for
the Family-wise error rate at a desired level (α = 5%). Software used
was JMP Statistical Discovery 4.0 (SAS Institute Inc., Cary, NC).
3. Results
3.1. Acrolein activates the ER stress survival response in A549 lung cells
3.1.1. Acrolein causes phosphorylation of ER stress sensors PERK, eIF2α and
IRE1α
The ER stress response is mediated by three membrane receptors,
PERK, IRE1α and ATF6. The exposure of cells to acrolein (15–50 μM)
caused phosphorylation of PERK after 15–30 min (Fig. 1A, B). Acrolein
did not alter total cellular expression of PERK (Fig. 1C, D). Activated
PERK phosphorylates eIF2α, thus attenuating translation to reduce the
Fig. 1. Acrolein causes phosphorylation of PERK in A549 cells.Western blot analysis of whole cell lysates prepared from A549 cells after exposure to acrolein (15–50 μM) for 15 or 30 min.
Representative Western blots (30 min) are shown for expression of (A) anti-phospho PERK or (C) total PERK, using GAPDH as a loading control. (B, D) Densitometric analyses of the
expression of (B) p-PERK and (D) PERK, after 15 and 30 min, are relative to the untreated control, designated as 100%. Western blots are not shown for 15 min. Data represent means
and SEM from four independent experiments performed with multiple estimations per point. *P b 0.05 or **P b 0.01 indicates a statistically signiﬁcant difference between treatment
with acrolein and the untreated control.
829A. Tanel et al. / Biochimica et Biophysica Acta 1843 (2014) 827–835load of newly synthesized proteins in the ER lumen [38]. Moreover,
acrolein caused phosphorylation of eIF2α after 30 min (Fig. 2A, B),
whereas total expression of eIF2α did not change (Fig. 2C, D).
The ER stress sensor IRE1α is activated by phosphorylation and
regulates transcription of genes involved in protein folding and
degradation, in order to restore ER homeostasis [39]. When A549
cells were treated with acrolein (15–50 μM) for 30 min, IRE1α was
phosphorylated (Fig. 3A, B), whereas there was no change in total
expression of IRE1α (Fig. 3C, D).
3.1.2. Acrolein causes cleavage of ATF6 and induction of ER chaperone BiP
Another response to ER stress is transcriptional activation of genes
for ER chaperones such as BiP. During ER stress, ATF6 translocatesFig. 2.Acrolein causes phosphorylation of eIF2α. RepresentativeWesternblots for analysis of exp
to acrolein (15–50 μM) for 15 or 30 min, using GAPDH as loading control. Densitometric analys
(100%). Data represent means and SEM from three independent experiments. *P b 0.05 indicat
control.from the ER to Golgi, undergoes cleavage and translocates to the
nucleus, where it activates the transcription of chaperones. BiP has
been implicated in the recognition and elimination of aberrant
polypeptides [40]. Acrolein (15–50 μM) caused cleavage of ATF6 to
generate a 36 kDa protein fragment after 30 min (Fig. 4A, B). In addi-
tion, the protein expression of BiP increased after 15 and 30 min
(Fig. 4D, E).
These ﬁndings show that acrolein (15–50 μM) induces ER stress
after short times of 15–30 min in A549 cells. Under these conditions,
acrolein did not cause cell death (data not shown), suggesting that the
induction of ER stress was a protective survival response. Subsequently,
we determinedwhether acrolein could cause apoptosismediated by the
ER.ression of (A) p-eIF2α and (C) total eIF2α inwhole cell lysates of A549 cells after exposure
es of the expression of p-eIF2α (B) and total eIF2α (D) are relative to the untreated control
es a statistically signiﬁcant difference between treatment with acrolein and the untreated
Fig. 3. Acrolein causes IRE1α phosphorylation in A549 cells. Western blot analysis of (A) p-IRE1α and (C) total IRE1α is shown for whole cell lysates of acrolein (15–50 μM)-treated A549
cells. Representative blots are shown from three individual experiments (GAPDH loading control). (B, D) Densitometric analyses for expression of p-IRE1α and IRE1α are relative to the
untreated control (100%). Means and SEM are from three independent experiments. *P b 0.05, **P b 0.01 or ***P b 0.001 indicates a statistically signiﬁcant difference between treatment
with acrolein and the untreated control.
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cells
3.2.1. Acrolein induces expression of ER apoptotic factor CHOP and apoptotic
cell death
A549 cells were exposed to acrolein and then assessed for induction
of ER-mediated apoptosis and characteristic downstream features such
as caspase activation, PARP cleavage and nuclear chromatin condensa-
tion. CCAAT/enhancer binding protein homologous protein (CHOP)/
growth arrest- and DNA damage-inducible gene 153 (GADD153), is a
transcription factor that is induced downstream from the PERK and
ATF6 pathways [41]. Acrolein (25–50 μM) caused a signiﬁcant increase
in protein expression of CHOP after 2 h, compared to untreated controls
(Fig. 5A, B). In addition, acrolein activated events in the execution phaseFig. 4. Proteolytic cleavage of ATF6 and induction of ER chaperone protein BiP in cells treatedw
tativeWestern blots developed using (A) ATF6 and (C) BiP antibodies are shown, usingGAPDHa
and (D) expression of BiP are relative to the untreated control (100%). Data representmeans an
signiﬁcant difference between treatment with acrolein and the untreated control.of apoptosis such as cleavage of DNA repair enzymePARP to generate an
85 kDa fragment (Fig. 6A, B), caspase-3 activation (Fig. 6C), externalisa-
tion of phosphatidylserine (PS) (annexin V labelling of cell membranes)
(Fig. 7A. B), and chromatin condensation (Hoechst 33258 staining)
(Fig. 7C, D). Under these conditions, levels of necrotic cells were less
than 5% (Fig. 7A, B).
3.2.2. Role of ER proteases in acrolein-induced apoptosis in human A549
cells
The mechanisms that regulate the ER-mediated pathway of apopto-
sis are not entirely understood [42]. However, caspase-12 (mouse)
[43,44] and caspase-4 (human) [45] have been identiﬁed as the initiator
caspases in this process. The putative activators of caspase-12 and
caspase-4 are calpains and caspase-7 [43–45]. Upon excessive ER stress,ith acrolein. A549 cells were treatedwith acrolein (15–50 μM) for 15 or 30 min. Represen-
s a loading control. Densitometric analyses of the levels of the (B) cleaved fragment of ATF6
d SEM from three independent experiments. *P b 0.05 or **P b 0.01 indicates a statistically
Fig. 5. Acrolein induces the apoptotic factor CHOP. A549 cells were treated with acrolein
(25–50 μM) for 2 h. (A) Levels of CHOP in lysates were analysed by Western blotting. A
representative blot is shown from four independent experiments (GAPDH loading
control). (B) Densitometric analysis is relative to the untreated control (100%). Means
and SEM are from four independent experiments. *P b 0.05 indicates a statistically
signiﬁcant difference between treatment with acrolein and the untreated control.
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caspase-4 or -12 and cleaves the pro-domain to initiate caspase process-
ing. Alteration of ER calciumhomeostasis can activate cytosolic calcium-
dependent proteases such as calpains. Therefore, the roles of calpain,
caspase-7 and caspase-4 were evaluated in acrolein-induced apoptosis
in A549 cells. Indeed, acrolein (25–50 μM) increased the enzymatic
activity of calpains after 2 h, compared to untreated controls (Fig. 8A).
Calpain activation was suppressed by a calpain inhibitor and the
calcium chelator BAPTA-AM (Fig. 8A). Calpain activity is controlled by
the endogenous inhibitor calpastatin, which reversibly binds and
inhibits calpains [46]. Acrolein signiﬁcantly decreased protein levels ofFig. 6.Activation of the execution phase of apoptosis by acrolein. A549 cells were incubatedwith
inwhole cell lysates byWestern blotting (GAPDH loading control). (A)A representative blot is sh
cleaved PARP is relative to the untreated control, (100%). (C) Caspase-3 activity in cell lysates w
three independent experiments performed with multiple estimations per point. ***P b 0.001 i
treated control.calpastatin, under conditions that activated calpains (Fig. 8B, C).
Furthermore, acrolein (25–50 μM) increased enzymatic activity of
caspase-7 after 2 h (Fig. 8D).
Subsequently, the ability of acrolein to activate the ER initiator
caspase-4was determined. Acrolein (25–50 μM) signiﬁcantly increased
the enzymatic activity of caspase-4 after 2 h (Fig. 9A). The involvement
of calcium, calpain and caspase-7 in caspase-4 activation was clariﬁed.
Indeed, acrolein-induced caspase-4 activation was totally suppressed
by the calcium chelator, or by inhibitors of calpain or caspase-7
(Fig. 9A). Furthermore, acrolein-induced chromatin condensation, a
culminate event in apoptosis, was completely inhibited by BAPTA-AM,
and partially blocked by inhibitors of calpain and caspase-4 (Fig. 9B).
These results show that acrolein induces apoptosis through the ER-
mediated pathway by a process that involves activation of ER initiator
caspase-4 by calpain and caspase-7.
4. Discussion
This study shows that acrolein can induce both ER stress and ER-
mediated apoptotic cell death in A549 human lung cells. The ER stress
response was activated by acrolein after shorter times (15 to 30 min),
whereas apoptosis through the ER pathway occurred after a longer
time of 2 h. To our knowledge, this is the ﬁrst study to show the roles
of calpains and the caspase proteases, caspase-7 and caspase-4, in
acrolein-induced apoptosis in lung cells.
The concentrations of acrolein in smoke from commercial cigarettes
in the USA and UK range from 3 to 260 μg/cigarette [47]. It has been
estimated that acrolein levels at the airway surface may be as high as
80 μM during cigarette smoking or inhalation of second hand smoke
[48]. Human acrolein exposure through atmospheric contact would
amount to 154 μg (2.75 μmol/24 h), which is similar to that generated
by smoking 2.5 cigarettes. An important source of exposure is cooking
with oil at temperatures of 180 °C, which releases large amounts of
acrolein (5–250 mg/kg oil) into the atmosphere [2]. A blood level
of 129 μM acrolein was achieved in a patient who died of acrolein-acrolein (25–50 μM) for 2 h. Native (116 kDa) and cleaved PARP (85 kDa)were detected
own from three independent experiments. (B) Densitometric analysis of the expression of
as expressed relative to the untreated control (1.0). Data represent means and SEM from
ndicates a statistically signiﬁcant difference between treatment with acrolein and the un-
Fig. 7.Acrolein induces externalisation of phosphatidylserine and chromatin condensation. Cells (106/ml)were either untreated (control) or treatedwith 25–50 μMacrolein for 2 h. (A, B)
Cells were stained with annexin V-FITC (x axis) and PI (y axis). One representative experiment is shown from ﬁve independent experiments. For each experiment, 20,000 cells were
analysed by FACscan to determine the percentage of annexin V+-labelled cells. (C, D) Cells were stained with Hoechst 33258 and PI and visualized by ﬂuorescence microscopy (magni-
ﬁcation 320×). The fractions of apoptotic are given relative to total cells. Data representmeans and SEM from ﬁve independent experiments. *P b 0.05 or **P b 0.01 indicates a statistically
signiﬁcant difference between treatment with acrolein and the untreated control.
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ranged from 0.5 to 10 μM in some brain regions of Alzheimer's patients
[8]. Therefore, the lowmicromolar doses used in this study appear to be
relevant to in vivo human exposures, although exposure times were
short compared to long-term exposure to chronic doses of acrolein.
4.1. Acrolein induces a protective survival response in A549 lung cells
Non-toxic levels of acrolein induced several signature ER stress
markers in A549 cells. The levels of survival/rescue molecules such as
p-PERK, p-eIF2α, p-IRE1α, cleaved ATF6 and BiP increased after 15 to
30 min of exposure to acrolein. These proteins had returned to control
levels by 45 min (data not shown), showing that ER stress was an
early and short-lived response. The rapidity of this response is consis-
tent with previous studies where exposure to 20 μM acrolein for
30 min severely depleted the antioxidant glutathione to less than 5%
of control levels [23,50]. Acrolein, at micromolar doses, is capable of
causing rapid and serious perturbation of the cellular redox equilibrium
[22,23,25], which could promote proteinmisfolding/unfolding. Acrolein
is known to cross-react with cysteine, histidine and lysine residues of
proteins [4,51,52] and to cause carbonylation of proteins [53,54].
The concept of dose and treatment time in experiments with acrole-
in is difﬁcult to assess due to its high reactivity. Most or all of the acro-
lein is likely to react rapidly with proteins in the medium as well as
directly with the cells [1,2,27]. Therefore, the effective dose of acrolein
seen by cells after different treatment times (e.g. 15 min, 2 h) is difﬁcult
to assess and is likely to be much lower. Our data are therefore
interpreted as changes in different cellular events in terms of “time
after treatment” because it is possible that all or most of the acrolein
could have reacted before the analysis times.
Under normal conditions, the three ER stress sensors PERK, ATF6 and
IRE1α remain inactive within the ER lumen by binding to BiP [55].
During ER stress, Bip releases these sensors and binds to misfolded/unfolded proteins. Synthesis of BiP is induced under stress conditions
that lead to accumulation of misfolded proteins in the ER [56]. ATF6
and IRE1α are responsible for the up-regulation of chaperones such as
BiP and other ER stress-related transcription factors [57]. PERK activa-
tion phosphorylates eIF2α, which suppresses protein translation until
ER homeostasis is restored [38]. PERK also activates the transcription
factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) [58], which
contributes to cellular redox homeostasis by regulating the antioxidant
response.
Under non-toxic conditions, acrolein activated the ER stress sensors
PERK, ATF6 and IRE1α and increased BiP expression in A549 cells. In
human umbilical vein endothelial cells (HUVECs), acrolein caused ER
stress, but not apoptosis [59]. Acrolein (2 to 10 μM) caused eIF2α phos-
phorylation after 10 to 30 min,whichwas followed by alternate splicing
of XBP-1 mRNA and increased expression of ATF4 after 2 h to 4 h [59].
ATF4 activates the transcription of Grp78/BiP and CHOP [42]. Indeed,
increased gene expression of Grp78/BiP and nuclear translocation of
CHOP occurred after 6 h in HUVECs [59]. In hepatocytes, acrolein
(50 μM, 24 h) activated eIF2α, increased levels of ATF4 and CHOP,
and caused cell death [60]. However, acrolein did not up-regulate the
adaptive/protective phase of ER stress involving the chaperones
GRP78/BiP and GRP94. Clearly, the activation of biochemical mecha-
nisms by acrolein is dependent on multiple factors, including cell type,
cellular environment, exposure time, concentration and redox equilib-
rium [1,2,23,27], as is the case for many other environmental contami-
nants and toxic drugs [61].
An in vivo study reported that systemic administration of acrolein
caused ER stress (up-regulation of ATF4, BiP and CHOP expression),
lung cell apoptosis (caspase-3 activation), and chronic administration
led to emphysema in rats [62].
The induction of survivalmechanisms upon exposure to lower doses
of toxic compounds is known as hormesis [63]. Some examples of
hormetic compounds are environmental toxins, drugs, oxidative stress,
Fig. 8. Acrolein increases activity of calpains and caspase-7. (A) A549 cells were pretreated with calcium chelator BAPTA-AM or calpain inhibitor for 1 h before the addition of acrolein
(25–50 μM) for 2 h. Calpain activity in cell lysates was expressed relative to the untreated control (1.0). (B, C) A representative Western blot from seven independent experiments is
shown for expression of total calpastatin (GAPDH loading control). Densitometric analysis of calpastatin expression is relative to the untreated control (1.0). (D) Caspase-7 activity in
cell lysates was expressed relative to the untreated control (1.0). Data represent means and SEM from seven independent experiments performed with multiple estimations per point.
*P b 0.05 or ***P b 0.001 indicates a statistically signiﬁcant difference between treatment with acrolein and the untreated control. ##P b 0.01 or ###P b 0.001 indicates a statistically
signiﬁcant difference between treatments (± inhibitor) for a given concentration of acrolein.
833A. Tanel et al. / Biochimica et Biophysica Acta 1843 (2014) 827–835heat shock, cold stress, radiation and hypoxia. In addition to the induc-
tion of ER stress in A549 and other cell types [59,64], ﬁndings from
several studies support the idea that acrolein can induce hormesis.Fig. 9. Calpain, caspase-7 and caspase-4 play a role in acrolein-induced apoptosis in A549 cells. C
or caspase-4 for 1 h and then incubatedwith acrolein (25–50 μM) for 2 h. (A) Caspase-4 activity
with Hoechst 33258 and visualized by ﬂuorescence microscopy. The fraction of apoptotic cel
experiments performed with multiple estimations per point. *P b 0.05, **P b 0.01 or ***P b 0.0
untreated control. ##P b 0.01 or ###P b 0.001 indicates a statistically signiﬁcant difference beNon-toxic doses of acrolein caused an anti-apoptosis response by induc-
ing survival factors such as inhibitor of apoptosis proteins (IAPs) and
AKT/protein kinase B in A549 cells [17]. Furthermore, acrolein inducedells were pretreatedwith orwithout a calcium chelator or inhibitors of calpain, caspase-7,
in cell lysateswas expressed relative to the untreated controls (1.0). (B) Cellswere stained
ls is given relative to total cells. Data represent means and SEM from three independent
01 indicates a statistically signiﬁcant difference between treatment with acrolein and the
tween treatments (± inhibitor) for a given concentration of acrolein.
834 A. Tanel et al. / Biochimica et Biophysica Acta 1843 (2014) 827–835the stress protein heme oxygenase 1 (HO-1) in human alveolar macro-
phages (5 μM, 4 h) [19], bovine aortic endothelial cells (BAEC) (10 μM,
3 h) [64] and primary rat astrocytes (10 μM, 24 h) [67]. The trans-
cription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in-
duces HO-1 through the antioxidant response element (ARE). Acrolein
induced Nrf2 translocation and ARE-luciferase reporter activity in
BAECs [64], and induced Nrf2 protein expression in astrocytes [65].
4.2. Acrolein induces apoptosis through the ER in A549 lung cells
Cells have a tightly regulated capacity to manage stress in the ER.
Once an adverse stimulus is removed, cells can often recover their
normal cellular function. If the level of stress is too severe and the UPR
is not able to rescue cells from ER stress, then signals will be activated
to eliminate the cell by apoptosis and/or necrosis [55]. In accordance,
while ER stress was induced after shorter times (15 to 30 min) follow-
ing acrolein treatment in A549 cells, the ER-mediated pathway of
apoptosiswas activated after a longer time (2 h). Thiswas characterised
by induction of ER apoptotic factor CHOP and the activation of calpain
and ER caspase-4. The PERK/eIF2α branch of the UPR is required for
up-regulation of CHOP expression, although details of the apoptosis
pathway downstream of CHOP are not clearly understood. CHOP
down-regulates the antiapoptotic protein Bcl-2 and renders cells
sensitive to the proapoptotic effects of BH3-only proteins such as Bim
[66].
The precise mechanisms that regulate apoptosis through the ER are
not completely understood. Several different pathways have been
implicated involving caspase-12/caspase-4, CHOP and IRE1-JNK [42].
Although caspases-12 and -4 have been implicated in ER stress-
induced apoptosis, the events responsible for their activation remain
ill-deﬁned. This study shows that calcium/calpain and caspase-7 are
among the initiating factors for the caspase-4 pathway in acrolein-
induced apoptosis through the ER in A549 cells. Once activated,
caspase-4 can activate caspase-9 and caspase-3 [67]. The partial inhibi-
tion of acrolein-induced apoptosis by inhibitors of calpain and caspase-4
could be explained by the fact that acrolein also activates apoptosis
through other pathways in A549 [17,68] and Chinese hamster ovary
cells [23,69]. Therefore, acrolein can activate the three main pathways
of apoptosis, involving death receptors [68], mitochondria [17], and
the ER, in A549 cells. There appears to be crosstalk and/or parallel
activation of different apoptotic pathways by toxic compounds such as
acrolein.
These results are relevant to the toxicity of acrolein in several
contexts, including respiratory diseases, as well as the biochemical
effects of chronic environmental exposures to acrolein. In addition,
acrolein is a metabolite of the anticancer agent cyclophosphamide
and has been implicated in its toxic side effects [70]. Acrolein is
also a metabolite of polyamines that are involved in the regulation
of cell proliferation and tumour growth [71]. This reactive aldehyde
is of interest from a public health perspective because long-term
chronic exposure to acrolein arises from both exogenous and endog-
enous sources.
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